Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Granules India Limited    532482   INE101D01020

GRANULES INDIA LIMITED

(532482)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Banks, IT lead rebound in Indian shares on fiscal stimulus hopes

09/25/2020 | 06:37am EST

BENGALURU, Sept 25 (Reuters) - Indian shares on Friday snapped their longest losing streak since February, boosted by financial and IT stocks, after a media report suggesting more domestic fiscal stimulus was on the way lifted sentiment.

The broader NSE Nifty 50 index rose 2.3% to 11,050.25 and the S&P BSE Sensex climbed 2.3% to 37,388.66, after falling for six straight sessions.

The Indian government was set to announce a stimulus package ahead of the festive season, aimed at creating jobs and pushing demand to lift the battered economy, a Moneycontrol report said.

Both Indian indexes, however, were down nearly 4% in their worst week since early-May, on worries over the impact of surging cases of the novel coronavirus on the global economic recovery.

"We may see little bounces ... Fundamentals are as weak as they were three months back," said Umesh Mehta, head of research at Samco Securities, Mumbai.

The Nifty IT sub-index climbed 3.5%, while the Nifty Bank index gained 2.6%.

The positive investor sentiment was also underpinned by a recovery in global shares on hopes of economic stimulus from the United States.

Shares of Granules India Ltd rose as much as 9.5% after a report said KKR, Bain Capital, Blackstone were in the race for a majority stake in the pharma company.

Shares of Vodafone Idea rose as much as 14.8%, after Reuters reported that the telecom operator's British parent, Vodafone Group Plc won an international arbitration case against Indian government.

India's Cipla rose 5.1% after it got a final approval from the U.S. FDA for a generic version of Biogen IDEC's multiple sclerosis drug Tecfidera. (Reporting by Nallur Sethuraman in Bengaluru; Editing by Vinay Dwivedi)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
CIPLA LIMITED 0.18% 757.5 Delayed Quote.58.01%
GRANULES INDIA LIMITED -0.05% 412.45 End-of-day quote.235.05%
KKR & CO. INC. 2.61% 38.92 Delayed Quote.33.42%
NIFTY 50 -0.05% 13114.6 Delayed Quote.6.58%
NIFTY IT -0.43% 22275.65 Delayed Quote.39.05%
SAMCO INC. 2.44% 3565 End-of-day quote.74.16%
SENSEX 30 1.15% 44655.44 Real-time Quote.8.25%
THE BLACKSTONE GROUP INC. 1.46% 60.42 Delayed Quote.8.01%
VODAFONE GROUP PLC -0.53% 124.84 Delayed Quote.-14.53%
VODAFONE IDEA LIMITED -1.00% 9.95 Delayed Quote.62.60%
All news about GRANULES INDIA LIMITED
12/01Indian shares rise on economic recovery signs, auto sales data eyed
RE
10/28GRANULES INDIA LIMITED : Ex-dividend day for interim dividend
FA
10/22GRANULES INDIA : receives US FDA approval for Potassium Chloride Extended Releas..
PU
09/25Banks, IT lead rebound in Indian shares on fiscal stimulus hopes
RE
09/25GRANULES INDIA : receives US FDA approval of Naproxen Sodium and Diphenhydramine..
PU
09/25Indian shares rebound on IT boost, state-run banks dip
RE
09/11GRANULES INDIA : Receives USFDA approval for complex, Attention Deficit Hyperact..
PU
08/05GRANULES INDIA LIMITED : Ex-dividend day for final dividend
FA
07/28GRANULES INDIA LIMITED : Ex-dividend day for interim dividend
FA
07/27GRANULES INDIA : Pharmaceuticals, Inc. issues clarification on media reports
PU
More news
Financials
Sales 2021 32 385 M 440 M 440 M
Net income 2021 5 397 M 73,3 M 73,3 M
Net Debt 2021 6 561 M 89,1 M 89,1 M
P/E ratio 2021 19,7x
Yield 2021 0,42%
Capitalization 106 B 1 444 M 1 441 M
EV / Sales 2021 3,48x
EV / Sales 2022 2,95x
Nbr of Employees 3 029
Free-Float 53,2%
Chart GRANULES INDIA LIMITED
Duration : Period :
Granules India Limited Technical Analysis Chart | 532482 | INE101D01020 | MarketScreener
Technical analysis trends GRANULES INDIA LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 446,50 INR
Last Close Price 428,60 INR
Spread / Highest target 28,3%
Spread / Average Target 4,18%
Spread / Lowest Target -23,7%
EPS Revisions
Managers
NameTitle
Krishna Prasad Chigurupati Chairman & Managing Director
GSR Prasad Chief Operations Officer
Sandip Neogi Chief Financial Officer
Arun Rao Akinepally Independent Non-Executive Director
Harsha Chigurupati Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GRANULES INDIA LIMITED235.05%1 444
JOHNSON & JOHNSON-0.82%380 876
ROCHE HOLDING AG-4.76%282 467
PFIZER, INC.3.21%212 942
NOVARTIS AG-10.48%206 479
MERCK & CO., INC.-11.61%203 389